#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
proLékaře.cz / Topic

Sartans in the Treatment of Hypertension

We recommend starší paní s demencí

Can Antihypertensives Reduce the Risk of Dementia? The Answer Suggests the Angiotensin Hypothesis and a Post-Hoc Analysis of an Observational Study

14. 8. 2023 Source: Sartans in the Treatment of Hypertension

The use of antihypertensives that do not reduce angiotensin II levels, such as angiotensin receptor blockers (ARBs, i.e., sartans) and calcium channel blockers (CCBs), has been associated with a lower risk of dementia in studies. In the research cited below, the authors aimed to determine whether this effect persists longer than the follow-up period in previous studies.

Žena si měří tlak a sahá si na hruď

Association Between Sartan Therapy and Lower Incidence of Epilepsy in Hypertensive Patients?

Arterial hypertension (AH) is one of the non-cerebral comorbidities of epilepsy, with the…
25. 5. 2023 Source: Sartans in the Treatment of Hypertension
doc. Petrák výřez

The main advantage of sartans is a very good safety profile. Now it is about increasing adherence in hypertensive patients

The rules for initiating hypertension treatment have been simplified. The trend is to achieve blood…
28. 3. 2023 Source: Sartans in the Treatment of Hypertension
Articles on this topic
leky na srdce

Relationship Between Mortality and Use of Statins or RAAS Inhibitors After Aortic Valve Replacement

The impact of prescribed medication after transcatheter aortic valve replacement (TAVR) has…
16. 3. 2023 Source: Sartans in the Treatment of Hypertension
léky na srdeční selhání

Administration of RAAS Inhibitors in Czech Patients with Heart Failure in Real Practice

A partial analysis of data from the national register of reimbursed health care focused on the…
24. 10. 2022 Source: Sartans in the Treatment of Hypertension
hypertenze a plíce

Impact of ACEi and ARBs on Lung Function in Patients with Hypertension

Worsening respiratory functions can significantly influence the choice of antihypertensive…
4. 10. 2022 Source: Sartans in the Treatment of Hypertension
covid srdce

Can the use of sartans reduce mortality and severity of COVID-19 in hypertensives?

Existing scientific and clinical evidence suggests the involvement of the renin-angiotensin-al…
21. 7. 2022 Source: Sartans in the Treatment of Hypertension
antihypertenzní léčba

Telmisartan, amlodipine, and chlorthalidone in a low-dose fixed triple combination –⁠ better control of target blood pressure values?

The secondary analysis of the TRIUMPH study, recently published in JAMA Cardiology, is likely…
15. 6. 2022 Source: Sartans in the Treatment of Hypertension
hypertenze a covid

Does the choice of therapy for primary hypertension in patients with COVID-19 affect the severity of the disease?

The effect of two commonly used antihypertensives was evaluated in a randomized clinical trial…
24. 3. 2022 Source: Sartans in the Treatment of Hypertension
hypertenze a srdce ilustrace

Telmisartan –⁠ antihypertensive with cardioprotective effects

Sartans are potent inhibitors of the AT1 receptor for angiotensin II widely used in the…
24. 3. 2022 Source: Sartans in the Treatment of Hypertension
hypertenze léky

Efficacy and Safety of the Combination of Telmisartan and Amlodipine with Hydrochlorothiazide in the Treatment of Hypertension

The aim of the study by Korean authors was to evaluate the efficacy and tolerability of the…
8. 2. 2022 Source: Sartans in the Treatment of Hypertension
fixní kombinace dvou účinných látek do jednoho léku

What Benefits Does the Fixed Combination of Candesartan/Amlodipine Bring?

A relatively new fixed combination used in the treatment of hypertension is represented by…
9. 12. 2021 Source: Sartans in the Treatment of Hypertension
lekari v ordinaci pocitac overeni informace

Can the Treatment of Hypertension Prevent Recurrence of Atrial Fibrillation?

Atrial fibrillation (Afib) is the most common serious heart rhythm disorder and is responsible…
3. 12. 2021 Source: Sartans in the Treatment of Hypertension
hypertenze lékař měření

Effect of Telmisartan and Losartan on Bone Turnover Markers in Patients with Newly Diagnosed Stage I Hypertension

Telmisartan, an AT1 receptor blocker for angiotensin II and partial agonist of the PPAR-γ…
12. 8. 2021 Source: Sartans in the Treatment of Hypertension
leky lék pod lupou srovnání léků farmaka účinná látka

The Anti-inflammatory and Renoprotective Effect of Candesartan May Be Independent of the AT1 Receptor

Candesartan belongs to the blockers of AT1 receptors (AT1R) for angiotensin II coupled with G…
12. 8. 2021 Source: Sartans in the Treatment of Hypertension
PL_duchodkyne_seniorka_pece

Can antihypertensive treatment also have a beneficial effect on neurocognitive functions?

Observational studies suggest that a desirable side effect of AT1 receptor blockers for…
14. 6. 2021 Source: Sartans in the Treatment of Hypertension
medicína_krev_krevní_tlak_měření_doktor_nemocnice

Are there mutual interactions between candesartan and amlodipine in the combination therapy of hypertension?

Monotherapy is often insufficient in the treatment of hypertension; however, combining…
14. 6. 2021 Source: Sartans in the Treatment of Hypertension
PL_zena_pacient_nemocnice_covid

Can sartans improve clinical outcomes in hypertensive patients with COVID-19?

Dysfunction of the renin-angiotensin system (RAS) has been detected in patients with COVID-19.…
19. 4. 2021 Source: Sartans in the Treatment of Hypertension
1 2
Subscribe
E-courses on this topic

Authors: MUDr. Libor Jelínek

Course detail

Authors: MUDr. Jiří Slíva, Ph.D.

Course detail
Most read on this topic
Journal on this topic
Issue 7–8
Journal of Czech Physicians
Issue 3
Cardiology Review
Issue 4
Transfusion and Haematology Today
Related topic
Interesting links
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#